Broad Institute

Broad Institute is a biomedical and genomic research center located in Cambridge, Massachusetts, United States. The institute is a collaboration between Massachusetts Institute of Technology (MIT), Harvard University, Harvard Medical School, and the five Harvard-affiliated hospitals. The Broad Institute aims to improve human health by using genomics to advance our understanding of the biology and treatment of human disease.

History[edit | edit source]

The Broad Institute was launched in 2004, with a $100 million commitment from philanthropists Eli and Edythe Broad. The institute was officially established as an independent nonprofit organization in 2009. The Broad Institute has made significant contributions to the field of genomics and has been instrumental in various large-scale, collaborative research projects, such as the Human Genome Project and the Cancer Genome Atlas.

Research[edit | edit source]

The Broad Institute conducts research in a wide range of areas, including cancer, cardiovascular disease, diabetes, psychiatric disorders, and infectious diseases. The institute's research is characterized by its interdisciplinary approach, combining expertise in biology, chemistry, computer science, medicine, and statistics to tackle complex challenges in human health.

Facilities[edit | edit source]

The Broad Institute's facilities include state-of-the-art laboratories, high-throughput sequencing centers, and advanced computational resources. The institute also houses the Broad Institute Data Sciences Platform, which provides a suite of software tools and services to support data-intensive biomedical research.

Collaborations[edit | edit source]

The Broad Institute collaborates with a global network of researchers and institutions. These collaborations aim to accelerate the pace of scientific discovery and translate findings into new treatments and therapies.